# Yttrium-90 Carbon Microsphere Radioembolization in Previously Treated Hepatocellular Carcinoma

> **NCT07657273** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Second Affiliated Hospital of Guangzhou Medical University** · enrollment: 20 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DRUG:** NRT6003 Injection

## Key facts

- **NCT ID:** NCT07657273
- **Lead sponsor:** Second Affiliated Hospital of Guangzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-22
- **Primary completion:** 2027-12-21
- **Final completion:** 2027-12-21
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07657273

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07657273, "Yttrium-90 Carbon Microsphere Radioembolization in Previously Treated Hepatocellular Carcinoma". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07657273. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*